DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,345,421 | -35.5% | 48,669 | -19.4% | 0.21% | -30.2% |
| Q2 2023 | $14,490,960 | -20.8% | 60,379 | -16.8% | 0.30% | -23.0% |
| Q1 2023 | $18,295,079 | -18.9% | 72,588 | -14.6% | 0.38% | -7.9% |
| Q4 2022 | $22,549,286 | +3.6% | 84,957 | +0.8% | 0.42% | -5.5% |
| Q3 2022 | $21,767,000 | +1.2% | 84,274 | -0.6% | 0.44% | +6.8% |
| Q2 2022 | $21,504,000 | -18.3% | 84,821 | -5.5% | 0.41% | -5.1% |
| Q1 2022 | $26,333,000 | -10.3% | 89,772 | +0.7% | 0.43% | -4.4% |
| Q4 2021 | $29,343,000 | +5.9% | 89,184 | -2.0% | 0.45% | -4.8% |
| Q3 2021 | $27,714,000 | +68.0% | 91,032 | +24.2% | 0.48% | +59.0% |
| Q1 2021 | $16,493,000 | -3.0% | 73,279 | -4.3% | 0.30% | -7.4% |
| Q4 2020 | $17,003,000 | +12.7% | 76,546 | +9.2% | 0.32% | -2.1% |
| Q3 2020 | $15,088,000 | +0.1% | 70,068 | -17.8% | 0.33% | -6.8% |
| Q2 2020 | $15,080,000 | +25.5% | 85,279 | -1.7% | 0.36% | +2.6% |
| Q1 2020 | $12,012,000 | -11.7% | 86,787 | -2.1% | 0.35% | +12.3% |
| Q4 2019 | $13,611,000 | -1.2% | 88,679 | -7.0% | 0.31% | -7.2% |
| Q3 2019 | $13,775,000 | +1.7% | 95,372 | +0.6% | 0.33% | +2.2% |
| Q2 2019 | $13,547,000 | +31.5% | 94,784 | +21.5% | 0.32% | +31.6% |
| Q1 2019 | $10,303,000 | +18.8% | 78,041 | -7.2% | 0.25% | -0.4% |
| Q4 2018 | $8,672,000 | -5.4% | 84,099 | -0.3% | 0.25% | +7.8% |
| Q3 2018 | $9,168,000 | +1.4% | 84,372 | -7.9% | 0.23% | -5.3% |
| Q2 2018 | $9,042,000 | -0.8% | 91,630 | -1.6% | 0.24% | -6.2% |
| Q1 2018 | $9,114,000 | +6.1% | 93,082 | +0.6% | 0.26% | +9.3% |
| Q4 2017 | $8,592,000 | +8.4% | 92,572 | +0.2% | 0.24% | +3.0% |
| Q3 2017 | $7,926,000 | +1.3% | 92,397 | -0.4% | 0.23% | -6.5% |
| Q2 2017 | $7,827,000 | +2.4% | 92,742 | +3.8% | 0.25% | +3.4% |
| Q1 2017 | $7,642,000 | +12.2% | 89,349 | +2.1% | 0.24% | +6.2% |
| Q4 2016 | $6,813,000 | -4.6% | 87,529 | -3.9% | 0.22% | -5.1% |
| Q3 2016 | $7,142,000 | -28.3% | 91,108 | -7.6% | 0.24% | -32.8% |
| Q2 2016 | $9,955,000 | +1.7% | 98,565 | -4.5% | 0.35% | -0.8% |
| Q1 2016 | $9,787,000 | +0.4% | 103,168 | -1.7% | 0.35% | +0.3% |
| Q4 2015 | $9,750,000 | +15.5% | 104,974 | +6.0% | 0.35% | +11.0% |
| Q3 2015 | $8,438,000 | -11.1% | 99,023 | -10.7% | 0.32% | -1.2% |
| Q2 2015 | $9,495,000 | +7.3% | 110,933 | +6.4% | 0.32% | +8.1% |
| Q1 2015 | $8,852,000 | +27.7% | 104,258 | +28.9% | 0.30% | +24.7% |
| Q4 2014 | $6,932,000 | -2.2% | 80,886 | -13.3% | 0.24% | +0.8% |
| Q3 2014 | $7,086,000 | -9.0% | 93,261 | -5.7% | 0.24% | -5.2% |
| Q2 2014 | $7,789,000 | +21.2% | 98,931 | +15.4% | 0.25% | +17.4% |
| Q1 2014 | $6,427,000 | -1.4% | 85,692 | +1.5% | 0.21% | -2.3% |
| Q4 2013 | $6,517,000 | +14.3% | 84,413 | +2.6% | 0.22% | +5.3% |
| Q3 2013 | $5,704,000 | +8.2% | 82,282 | -1.2% | 0.21% | +4.0% |
| Q2 2013 | $5,274,000 | – | 83,311 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |